The Department of Health and Aged Care have advised the Take Home Naloxone (THN) Program has been updated to include an additional brand of Naloxone: NALOXONE SXP (naloxone hydrochloride 400 microgram/mL injection, 5×1 mL ampoules).
Approved Service Providers and Authorised Alternative Suppliers may provide NALOXONE SXP under the THN Program from 1 August 2023 and lodge claims/data containing NALOXONE SXP into the PPA Portal.
Please Note: claims and data should not be submitted for NALOXONE SXP supplied prior to 1 August 2023. Claims submitted by an Approved Provider containing NALOXONE SXP products with a date of supply prior to 1 August 2023 will receive a payment of $0 for the NALOXONE SXP component of the claim.
As per existing Program Rules, Authorised Alternative Suppliers do not receive payment for handing out naloxone products under the THN Program.